Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Finnfund invests in ADP III to foster growth and development of African businesses

Finnfund, a Finnish development financier and impact investor, today announce a USD26 million commitment to African Development Partners III (ADP III), a pan-African private equity fund aiming to foster the growth and development of African consumer focused businesses across the continent.Contributing to the value creation within its investees, ADP III aims to support established and growing consumer focused businesses to improve their processes and expand regionally across Africa. The fund provides companies with growth capital and know-how aiming to contribute to job creation, climate

SBB controls 96.9 percent of shares in Offentliga Hus and extends the acceptance period for the mandatory public offer

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further registration documents, filings or other measures in addition to those required under Swedish law. On 18 December 2020, SBB announced an acquisition corresponding to 54.3 percent of the total shares and votes

XNK Therapeutics appoints Dr. Johan Aschan as Chief Medical Officer

April 14, 2021 XNK Therapeutics AB (“XNK”) today announced the appointment of Dr. Johan Aschan as Chief Medical Officer, effective July 1[st]. He will be member of the company’s management team.Dr. Aschan received his MD from Karolinska Institutet (KI) in 1985 and his PhD in Clinical Immunology from KI in 1994. He has extensive experience from work within the field of allogenic stem cell transplantation at the Karolinska University Hospital in Huddinge, Sweden, and from various leadership roles within hematology and oncology at Janssen. Most recently, prior to joining XNK, Dr. Aschan

Invitation to Kindred Group’s presentation of the Interim report for the first quarter 2021

Kindred Group plc will publish its Interim report for the first quarter 2021 on Wednesday 28 April 2021 at 07.30 (CEST). In connection with this, Kindred Group’s CEO Henrik Tjärnström will host a web presentation in English at 09.00 (CEST) which is web casted live on www.kindredgroup.com/Q12021. For those who would like to participate in the telephone conference in connection with the presentation, please call: UK: +44 33 3300 9273  USA: +1 833 5268 347 Please call in well in advance for registration. There will be an opportunity to ask questions after the presentation.

Scandic recruits new Chief HR Officer

Scandic has recruited Fredrik Wetterlundh as new Chief Human Resources Officer for Scandic Hotels Group. Fredrik will start in August and be a member of Scandic’s Executive Committee. Most recently, Fredrik has been working in a position with global responsibility within human resources for mergers and acquisitions at Ericsson.Fredrik Wetterlundh has held senior positions within HR at several large organizations including Sobi, Pfizer, Kraft Foods (now Mondelez) and Astra Zeneca. Most recently, he has been working at Ericsson with responsibility, among other things, for driving change

KONE publishes January-March 2021 Interim Report on Wednesday, April 28, 2021 at 12:30 p.m. EEST

KONE Corporation, press release, April 14, 2021 at 9.30 a.m. EESTInterim ReportKONE Corporation will publish its Interim Report for the January 1-March 31, 2021 accounting period on Wednesday, April 28, 2021 at 12:30 p.m. EEST. The report will be available on www.kone.com after publishing. Press and analyst eventsA Microsoft Teams call for the press, conducted in English, will be held on Wednesday, April 28, 2021 at 2:15 p.m. EEST. Journalists are kindly asked to sign up to media@kone.com by Tuesday, April 27, 2021, and they will receive a link to the call upon registration. A

Employees become patrons of Wallenstam’s newly constructed properties

Wallenstam’s newly produced residential properties will receive personal patrons in the form of the employees who have worked the longest time in the company. Ulf Lundberg, who works as a regional controller, recently got to participate when a name plaque bearing his name was mounted on the Rosengången block in Mölnlycke Fabriker.“Patronship is a recognition of our appreciation for engagement and loyalty to Wallenstam as a company. The employees who so far have been able to become a patron have worked in the company for an average of 25 years,” says Hans Wallenstam, CEO of Wallenstam.

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Invitation to the presentation of Alimak Group´s report for the first quarter 2021

Alimak Group’s interim report for January-March 2021 will be published on April 22, 2021 at 08:00 CET.A telephone conference for investors, analysts and financial media will be held at 10.00 CET on Thursday April 22, 2021. CEO Ole Kristian Jødahl and Interim CFO Bernt Ingman will present and comment on the report. The presentation, held in English, can also be followed via audiocast. To participate by phone – please call: DK: +45 78150107 SE: +46 850558358 UK: +44 3333009270 US: +1 8332498404 Link to audiocast: https://streams.eventcdn.net/alimak/q1-2021/ For more

Metsä Fibre and Raumaster signed machinery supply agreements for the Kemi bioproduct mill in Finland

Metsä Fibre press release 14.4.2021Metsä Fibre, part of Metsä Group, has signed machinery supply agreements for the new Kemi bioproduct mill with Raumaster Oy and Raumaster Paper Oy. Raumaster Oy will supply the machinery used in the chip and bark processing area, the conveyor systems for the gasifier and recovery boiler, and most of the conveyors for lime, lime mud processing and causticising. Raumaster Paper Oy will supply automated bale loading and unloading equipment for the port warehouse to be constructed in Ajos harbour in Kemi. The deliveries have a high degree of Finnish origin,

Completed sale of shares in Readly International AB

14 April 2021 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW.Cleantech Europe II Luxembourg Sarl and Readly Co-Investment LP (jointly “Zouk Capital”) have today, 14 April 2021, sold approximately 3 million shares in Readly International AB (“Readly”) on

Elisa: Q1 Interim Report publication on 21 April 2021

ELISA CORPORATION INVESTOR NEWS 14 APRIL 2021 AT 9:00 AMElisa will publish its Q1 2021 Interim Report on Wednesday 21 April 2021 at approximately 8:30 am EET (6:30 UK time). International conference call for analysts and investors will be held on the same day at 12:00 pm EET. Dial-in numbers for the conference call, PIN: 49105807# · FI: +358 981 710 310 · SE: +46 856 642 651 · UK: +44 333 300 0804 · US: +1 631 913 1422 Audiocast: https://elisa.videosync.fi/2021-q1-results The presentations and later recording of the audiocast will be available on elisa.com/

Flexion’s strong momentum continues in the 4th quarter - beating its own expectations with an estimated total revenue growth of 136%

LONDON, 14th of April 2021 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today releases its 4[th] quarter trading update which completes an exceptionally strong financial year where the company grew its core business with an estimated 160%. Flexion estimates revenue and margin growth above expectations for the traditionally slower 4th quarter. Gross margin was slightly more volatile than revenue, partly due to FX effects and to short term movement of key titles.Quarterly estimates for March 2021: Revenue · IAP revenue estimated to increase by 144% (

The Tensor IxB platform by Atlas Copco revolutionizes the Smart Factory

Stockholm, Sweden, April 14, 2021: Atlas Copco continues to evolve their Smart Connected Assembly. The Tensor IxB family is a collection of handheld, cordless tools, which share an integrated controller platform. This is the first generation of Atlas Copco tools with integrated controllers – all innovatively designed to enable future requirements of customers. With the Tensor IxB platform, customers get a tool family which is lighter, faster and smaller, yet has the same, powerful performance of cabled tools.Atlas Copco first presented Smart Connected Assembly in 2017, as its contribution

AFRY signs agreement to acquire Evolve Technology Sweden

In line with AFRY’s strategy to increase growth and be a leader in industrial digitalisation, AFRY is acquiring systems and software company Evolve to strengthen its digital offering.Evolve focuses on software development and digital services in areas such as medtech, finance, retail and cyber security. Evolve mainly works with challenging software development projects for new digital products and domains. The company was founded in 2017. AFRY’s digital end-to-end offering will be strengthened thanks to the acquisition of Evolve and their focus on senior digital architects and developers.

Tagrisso approved in China in early lung cancer

14 April 2021 07:00 BST Tagrisso approved in China for the adjuvant treatmentof patients with early-stage EGFR-mutated lung cancer Tagrisso is the only targeted medicine to show efficacy in the treatment of early-stage lung cancer in a global trial and the first such medicine approved in China Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80% AstraZeneca's Tagrisso (osimertinib) has been approved in China for the adjuvant treatment of patients with early-stage (IB, II and IIIA)

Metso Outotec introduces a comprehensive range of smart and sustainable mining filtration solutions

Metso Outotec Corporation’s press release on April 14, 2021, at 09:00 a.m. EESTMetso Outotec is launching a comprehensive range of smart and sustainable filtration solutions to meet the needs of the mining industry, including the most demanding concentrates and tailings dewatering applications. The selection includes 15 different filter types, ranging from pressure filters of up to 100 bar pressure to vacuum filters and polishing filters, coupled with an unmatched global service portfolio. The well-known Larox® brand, of which Metso Outotec is the sole owner, will be reintroduced as a

Invitation to Electrolux Q1 presentation

Electrolux results for the first quarter of 2021 will be published on April 28, 2021, at approximately 08.00 CET.A telephone conference will be held following the release of the results, starting at 09.00 CET. Jonas Samuelson, President and CEO and Therese Friberg, CFO will comment on the report. Slides used in the presentation and report will be available at Electrolux website, www.electroluxgroup.com/ir You can listen to the presentation here . The details for participation by telephone are as follows: Participants in Sweden should

Annual reports 2020 – exchange-traded funds managed by Handelsbanken Fonder AB

The annual reports for the following exchange-traded funds have been completed for the full-year 2020 and will be released today. The reports are available on the Management Company’s websites at xact.se and handelsbanken.se/en/personal/savings/mutual-funds/fund-reports. · XACT BEAR (ETF) · XACT BEAR 2 (ETF) · XACT BULL (ETF) · XACT BULL 2 (ETF) · XACT Norden (UCITS ETF) · XACT Nordic High Dividend Low Volatility (UCITS ETF) · XACT Obligation (UCITS ETF) · XACT OBX (UCITS ETF) · XACT OBX BEAR (UCITS ETF) · XACT OBX BULL (UCITS ETF) · XACT OMXC25 (UCITS ETF)

Hansa Biopharma to host conference call to provide interim results from Q1 2021 and Business Update

Lund, Sweden April 14, 2021 Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-March 2021 at 8:00 CET on April 22, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events &

Notice to the Annual General Meeting

The shareholders of Nordic Entertainment Group AB (publ) (“NENT”) are hereby invited to the Annual General Meeting on Wednesday 19 May 2021. +------------------------------------------------------------------------------+|INFORMATION REGARDING PARTICIPATION IN THE ANNUAL GENERAL MEETING 2021 ETC. || ||Due to the ongoing corona pandemic and for the safety of NENT's shareholders, ||NENT's Board has decided that the Annual General Meeting shall be conducted ||only by postal voting pursuant to

12 patients have been randomized in the NeoFox study during the first quarter of 2021

Patient recruitment for the ongoing Phase IIa clinical study NeoFox with WntResearch's drug candidate Foxy-5 continues. Despite a significant negative impact of covid-19, an aditional 12 patients were randomized during the first quarter of 2021 totaling the number of randomisez patients to 70.The recruitmentrate of new patients in the study is currently reduced since only half of the participating clinics in the study are actively recruiting. WntResearch aims to increase the recruitmenrate during the summer by restoring full activity at all 28 participating clinics in Hungary and Spain,

Konecranes’ January-March 2021 interim report will be published on April 28, 2021

KONECRANES PLC PRESS RELEASE April 14, 2021 at 09:00 EEST Konecranes’ January-March 2021 interim report will be published on April 28, 2021 Konecranes will publish its January-March 2021 interim report on Wednesday, April 28, 2021 at approximately 8:30 a.m. EEST. The report will be available on the company’s website at www.konecranes.com after publishing. A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:30 a.m. EEST. The event will be held in English. The January-March 2021 interim report will be presented by

Tokmanni Group Corporation will publish its first quarter 2021 business review on 29 April 2021

Tokmanni Group Corporation        Investor news        14 April 2021 at 9:00 amTokmanni will publish its first quarter 2021 business review on 29 April 2021 at approximately 8:30 am (Finnish time). The stock exchange release and the presentation materials in Finnish and in English will be available on the company's website at https://ir.tokmanni.fi/en as soon as possible after the publication of the report. Tokmanni’s CEO Mika Rautiainen and CFO Markku Pirskanen will present the review to analysts, investors and media representatives on the publication day at 11:30 am in English (Finnish

There are no items matching the current filter
There are no more items matching the current filter
Back to top